Nucleolin acute degradation reveals novel functions in cell cycle progression and division in TNBC
Joseph Mills, Anna TessariiD, Vollter AnastasiD, Damu SunilkumariD, Nastaran Samadi Rad, Saranya Lamba, Ilaria CosentiniiD, Ashley B. ReersiD, Zirui ZhuiD, Wayne O. MilesiD, Vincenzo CoppolaiD, Emanuele CocucciiD, Thomas J. MaglieryiD, Heather R. ShiveiD, Alexander E. DaviesiD, Lara RizzottoiD, Carlo Maria CroceiD, Dario PalmieriiD
Abstract
Nucleoli are large nuclear sub-compartments where vital processes, such as ribosome assembly, take place. Technical obstacles still limit our understanding of the biological functions of nucleolar proteins in cell homeostasis and cancer pathogenesis. Since most nucleolar proteins are essential, their abrogation cannot be achieved through conventional approaches. Additionally, the biological activities of many nucleolar proteins are connected to their physiological concentration. Thus, artificial overexpression might not fully recapitulate their endogenous functions. Proteolysis-based approaches, such as the Auxin Inducible Degron (AID) system paired with CRISPR/Cas9 knock-in gene-editing, have the potential to overcome these limitations, providing unprecedented characterization of the biological activities of endogenous nucleolar proteins. We applied this system to endogenous nucleolin (NCL), one of the most abundant nucleolar proteins, and characterized the impact of its acute depletion on Triple-Negative Breast Cancer (TNBC) cell behavior. Abrogation of endogenous NCL reduced proliferation and caused defective cytokinesis, resulting in bi-nucleated tetraploid cells. Bioinformatic analysis of patient data, and quantitative proteomics using our experimental NCL-depleted model, indicated that NCL levels are correlated with the abundance of proteins involved in chromosomal segregation. In conjunction with its effects on sister chromatid dynamics, NCL abrogation enhanced the anti-proliferative effects of chemical inhibitors of mitotic modulators such as the Anaphase Promoting Complex. In summary, using the AID system in combination with CRISPR/Cas9 for endogenous gene editing, our findings indicate a novel role for NCL in supporting the completion of the cell division in TNBC models, and that its abrogation could enhance the therapeutic activity of mitotic-progression inhibitors.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 1.89
- Field percentile
- top 15%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Downregulation of NCL attenuates tumor formation and growth in cervical cancer by targeting the PI3K/AKT pathway
- CYCLON is a nucleolar protein that regulates pan-cancer cell fitness through ribosome biogenesis
Andrea Cecilia Garcia-Sandoval, Sébastien Durand, … Anouk Emadali·bioRxiv·May 15, 2026
- Disruption of nucleolar integrity triggers cellular quiescence through organelle rewiring and secretion
Prashant Rawat, Tabea Quaderer, … Matthias Peter·bioRxiv·Aug 28, 2025
- Distinct states of nucleolar stress induced by anti-cancer drugs
T. A. Potapova, J. R. Unruh, … J. L. Gerton·bioRxiv·Nov 18, 2022
- SMALL MOLECULE CLPP AGONISTS INDUCE SENESCENCE AND ALTER TRAIL-MEDIATED APOPTOTIC RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER CELLS
L. J. Aponte-Collazo, E. M. J. Fennell, … L. M. Graves·bioRxiv·Jul 11, 2022
- Quinolinic acid phosphoribosyl transferase moonlights as an apoptosis regulator to empower lung cancer progression
Hossein Kashfi, Didem Ilter, … Ana P. Gomes·bioRxiv·Apr 3, 2026